1. Decreasing expression of HIF-1α, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer
   Ke Zhao et al, 2023, Medicine CrossRef
2. PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer
   Ahmad Reza Panahi Meymandi et al, 2024, Frontiers in Oncology CrossRef
3. Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature
   Linlin Liu et al, 2023, Diagnostic Pathology CrossRef
4. Role of Oxygenation Factor Hypoxia-inducible Factor-1α (HIF-1α) as Prognostic Indicators in Cervical Cancer
   I Wayan Megadhana et al, 2023, Journal of South Asian Federation of Obstetrics and Gynaecology CrossRef
5. A prognostic hypoxia gene signature is associated with a dampened tumour immune microenvironment in cervical cancer
   Salem Chouaib et al, 2023, Hamdan Medical Journal CrossRef
6. FOXP3 Isoforms Expression in Cervical Cancer: Evidence about the Cancer-Related Properties of FOXP3Δ2Δ7 in Keratinocytes
   Natalia Garcia-Becerra et al, 2023, Cancers CrossRef
7. Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients
   Zhengtian Li et al, 2021, Medicine CrossRef